These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27433524)

  • 21. Role of the ETB receptor in retinal ganglion cell death in glaucoma.
    Krishnamoorthy RR; Rao VR; Dauphin R; Prasanna G; Johnson C; Yorio T
    Can J Physiol Pharmacol; 2008 Jun; 86(6):380-93. PubMed ID: 18516102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage.
    Morgan JE
    Eye (Lond); 2000 Jun; 14 ( Pt 3B)():437-44. PubMed ID: 11026971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical potential of lomerizine, a Ca2+ channel blocker as an anti-glaucoma drug: effects on ocular circulation and retinal neuronal damage.
    Hara H; Toriu N; Shimazawa M
    Cardiovasc Drug Rev; 2004; 22(3):199-214. PubMed ID: 15492768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing therapeutic paradigms in glaucoma management.
    David R
    Expert Opin Investig Drugs; 1998 Jul; 7(7):1063-86. PubMed ID: 15992016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy.
    Vorwerk CK; Gorla MS; Dreyer EB
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S142-50. PubMed ID: 10416757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina.
    Lambuk L; Jafri AJ; Arfuzir NN; Iezhitsa I; Agarwal R; Rozali KN; Agarwal P; Bakar NS; Kutty MK; Yusof AP; Krasilnikova A; Spasov A; Ozerov A; Ismail NM
    Neurotox Res; 2017 Jan; 31(1):31-45. PubMed ID: 27568334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The nitric oxide-guanylate cyclase pathway and glaucoma.
    Wareham LK; Buys ES; Sappington RM
    Nitric Oxide; 2018 Jul; 77():75-87. PubMed ID: 29723581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mechanism study on trans-lamina cribrosa pressure difference correlated with optic neuropathy in glaucoma].
    Liang Q; Liu X
    Zhonghua Yan Ke Za Zhi; 2014 Oct; 50(10):798-800. PubMed ID: 25547585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of exercise on intraocular pressure and ocular blood flow: a review.
    Risner D; Ehrlich R; Kheradiya NS; Siesky B; McCranor L; Harris A
    J Glaucoma; 2009 Aug; 18(6):429-36. PubMed ID: 19680049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology of primary open-angle glaucoma from a neuroinflammatory and neurotoxicity perspective: a review of the literature.
    Evangelho K; Mogilevskaya M; Losada-Barragan M; Vargas-Sanchez JK
    Int Ophthalmol; 2019 Jan; 39(1):259-271. PubMed ID: 29290065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects.
    Resch H; Karl K; Weigert G; Wolzt M; Hommer A; Schmetterer L; Garhöfer G
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):358-63. PubMed ID: 18719081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood flow in glaucoma.
    Grieshaber MC; Flammer J
    Curr Opin Ophthalmol; 2005 Apr; 16(2):79-83. PubMed ID: 15744136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational Basis for Nutraceuticals in the Treatment of Glaucoma.
    Morrone LA; Rombola L; Adornetto A; Corasaniti MT; Russo R
    Curr Neuropharmacol; 2018; 16(7):1004-1017. PubMed ID: 29119928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers and special features of oxidative stress in the anterior segment of the eye linked to lens cataract and the trabecular meshwork injury in primary open-angle glaucoma: challenges of dual combination therapy with N-acetylcarnosine lubricant eye drops and oral formulation of nonhydrolyzed carnosine.
    Babizhayev MA
    Fundam Clin Pharmacol; 2012 Feb; 26(1):86-117. PubMed ID: 21883446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purinergic dysregulation causes hypertensive glaucoma-like optic neuropathy.
    Shinozaki Y; Kashiwagi K; Namekata K; Takeda A; Ohno N; Robaye B; Harada T; Iwata T; Koizumi S
    JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma.
    Harada T; Harada C; Nakamura K; Quah HM; Okumura A; Namekata K; Saeki T; Aihara M; Yoshida H; Mitani A; Tanaka K
    J Clin Invest; 2007 Jul; 117(7):1763-70. PubMed ID: 17607354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension.
    Trost A; Motloch K; Bruckner D; Schroedl F; Bogner B; Kaser-Eichberger A; Runge C; Strohmaier C; Klein B; Aigner L; Reitsamer HA
    Exp Eye Res; 2015 Jul; 136():59-71. PubMed ID: 26001526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis.
    Kimura A; Namekata K; Guo X; Noro T; Harada C; Harada T
    Oxid Med Cell Longev; 2017; 2017():2817252. PubMed ID: 28270908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial dysfunction in glaucoma.
    Resch H; Garhofer G; Fuchsjäger-Mayrl G; Hommer A; Schmetterer L
    Acta Ophthalmol; 2009 Feb; 87(1):4-12. PubMed ID: 18507728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.